この中にヴァカンティが小保方さんの受け入れと自分の説の関係に言及しているところがあるわね。
>>
In 2002, Vacanti went to Brigham and Women’s as the head of anesthesiology, and opened a large tissue-engineering lab. Recognizing that the pursuit of stress-altered cells was well outside his area of expertise, he hoped to hire someone who could help. Several years later, a Japanese colleague mentioned that he had a talented student—at the top of her class in chemical engineering at Waseda University—who was looking for a tissue-engineering project. It was Haruko Obokata.
When Obokata arrived in Vacanti’s lab, he quickly recognized her as open-minded and astute. Thinking that she could add credibility and detail to his work on the sporelike cells, he asked her to recapitulate the study, employing the latest techniques in stem-cell research. For the time being, he withheld his hypothesis that harsh conditions could create stem cells. The last thing he wanted was for a graduate student from abroad to return home and develop the idea in someone else’s lab. His main concern, he told me, was: “Can we trust Haruko?”
⑥が昨日紹介したデイナ・グッドイヤーさんが記事に書いた部分ね。
<The last thing he wanted was for a graduate student from abroad
to return home and develop the idea in someone else’s lab.
His main concern, he told me, was: “Can we trust Haruko?”>
この部分はさすがにこの間の事情を調べた人でないと意味が分からないわよね。
確かに端折りすぎだわ。someone else’s labって若山研のことね。
そこは若山さんが提示した待遇条件はそれほどのものとは思えないんだよな。
手記は願ってもないことと書いてるけど、米国での待遇の方がいい筈なんだけどな。
ただ、自分の研究のためには今のGOFマウスの使える環境が欲しいんだね。そこのところは
手記は本音を書いてるんじゃないか。でも誘ってもらっているので若山研に行きたいと
行ったかどうかは怪しいよね。彼女は既にヴァカンティ研のポスドク契約をしているでしょ。
信義としてもおかしな話だ。それにヴァカンティがこの時考えていたのは
His main concern, he told me, was: “Can we trust Haruko?”ということ
だったんでしょ。つまり彼女を理研へ海外出張に出させて秘密保持は大丈夫かと心配した。
